The global hyaluronic acid dermal filler market is anticipated to reach USD 6.06 billion by 2026. The market is expected to register a growth of 8.35% CAGR during the forecast period. This global growth can be attributable to growing awareness and importance of quality of life and overall health among the population worldwide. Additionally, scientific developments and technical innovations in the industry are likely to encourage the market growth further. In 2016, as per the International Society of Plastic Surgery (ISAPS), hyaluronic acid based dermal filler measures were the second-most preferred injectable procedures across the globe.
Rising disposable income and strong influence of social media are the key factors encouraging the global hyaluronic acid dermal filler market growth. Moreover, technological advancements resulting in reduced procedure and recovery time are likely to augment the demand over the forecast period. This global growth can be attributable to growing awareness and importance of quality of life and overall health among the population worldwide. Additionally, scientific developments and technical innovations in the industry are likely to encourage the market growth further.
In 2016, as per the fact provided by the International Society of Plastic Surgery, near about 8,500,000 non-surgical procedures were performed worldwide. This increase in health awareness and consciousness concerning the change in beauty standards among the population have led to a rise in demand for cosmetics and aesthetics procedures. This factor is also expected to have a positive impact on the global hyaluronic acid dermal filler market development.
The hyaluronic acid dermal fillers are frequently used for aesthetic procedures, such as reducing eye wrinkles, dark circles, scars, and improving nasolabial folds. Hyaluronic acid injections are characterised by ease of usage, relatively less expensive and comparatively highly effective. These coupled factors are expected to drive the growth of the global hyaluronic acid fillers market during the forecast period. Growing popularity and awareness of aesthetic measures for cosmetic makeover along with the easy availability of hyaluronic acid-based synthetic products which are FDA-approved, such as Juvederm, Perlane, Hylaform Plus, and Restylane, are also expected to drive the market growth during the forecast period.
Market By Product
Market By Application
Market By Geography
In 2017, among the regions, the North America hyaluronic acid dermal filler market held greater market share on account of higher number of minimally invasive cosmetic surgeries performed in the region. Asia Pacific hyaluronic acid dermal filler market is expected to witness greater CAGR during the forecast period, due to growing awareness about applications of minimally invasive techniques in emerging economies, such as China, and increasing disposable income levels.
The key players catering to the global hyaluronic acid dermal filler market are Genzyme Corporation, ALLERGAN PLC; Galderma S.A.; Medicis Aesthetics Holdings, Inc.; Anika Therapeutics, Inc. and Merz Pharma GmbH & Co. KGaA. The global players are continuously investing in R&D activities and innovating to have updated product portfolio to attract more and more business opportunity from the emerging nation such as that in Asia Pacific countries. Further changing customers’ preferences are encouraging global players to develop user friendly products with best experience for the users to cater best to the market. Also, Increasing R&D investments coupled with technological advancements to commercialise highly efficient products are anticipated to offer lucrative opportunities for industry participants.
Healthcare drones provide medical care facilities for the people in a few minutes to bring blood, medicines, serum snake bite, birth control, and other resources to rural areas, which in some situations could be the difference between life and death. Market Insights Increased awareness of healthcare drones is likely to fuel dema
The Global Metal Implants and Medical Alloys Market size is expected to garner around US$ 19.5 Bn by 2026, growing at a CAGR of around 9.2% over the forecast period 2019 to 2026. Metal implants are the biomaterials that are used to place inside or on the surface of the body. These are basically made up of stainless steel, Cobalt Chrome (CoCr) alloys, Titanium (Ti), and Ti alloys are widely used in orthopedic i
The Global Next Generation Sequencing Market is expected to grow at a CAGR of around 18.7% over the forecast period 2019 to 2026 and poised to reach around US$ 20.4 Bn by 2026. Next Generation Sequencing (NGS) is a platform that enabled the sequencing of thousands to millions DNA molecules simultaneously. It is also known as the massively parallel sequencing technology. This sequencing helps in the various fie
The global ultrasound equipment market is expected to grow at a CAGR of around 6.3% from 2019 to 2026 and expected to reach the market value of around US$ 10 Bn by 2026. Ultrasound is a medical imaging technology that uses sound waves to produce pictures of body’s inside part. It helps to diagnose swelling, pain, and infection in internal organs and to examine a baby in pregnant women. Ultrasound is also
The global minimally invasive surgery market is expected to grow at a CAGR of around 9.6% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 33.8 Bn by 2026. Minimally invasive surgery uses techniques to operate with less incision or damage to the body than open surgery. Hence, it is associated with less pain, fewer postoperative complications, and short
The global implantable medical devices market is expected to grow at a CAGR of around 7.3% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 153.8 Bn by 2026. An implant is a medical device, manufactured to support or replace any damaged organs in the body, treat imperfections in normal body functions, or enhance the functioning of body organs. These can be implanted by